ACS chemical neuroscience molecule spotlight on dimebon

ACS Chemical Neuroscience

Volumn 1, Issue 9, 2010, Pages 587-588

  Hopkins, Corey R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AD; Alzheimer's Disease; clinical trials; Dimebon; Neurodegeneration

Indexed keywords

DIMEBON; LATREPIRDINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG STRUCTURE; HEALTH CARE COST; HUMAN; HUNTINGTON CHOREA; PRIORITY JOURNAL; RUSSIAN FEDERATION; SHORT SURVEY;

AD; ALZHEIMER'S DISEASE; CLINICAL TRIALS; DIMEBON; NEURODEGENERATION;

ALZHEIMER DISEASE; ANIMALS; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; INDOLES; NEUROSCIENCES; SOCIETIES, SCIENTIFIC;

EID: 77956658482     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn1000588     Document Type: Short Survey

References (6)

1. www.alz.org.
2. Lermontova, N. N., Lukoyanov, N. V., Serkova, T. P., Lukoyanova, E. A., and Bachurin, S. O. (2000) Dimebon improves learning in animals with experimental Alzheimer's disease Bull. Exp. Biol. Med. 129, 544-546
3. Doody, R. S., Gavrilova, S. I., Sano, M., Thomas, R. G., Aisen, P. S., Bachurin, S. O., and Hung, D. (2008) Effect of dimebon on cognition, activities of daily living, behavior, and global function in patients with mild-to-moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled study Lancet 327, 207-215
4. Medivation press release, Sep 3, 2008. http://investors.medivation.com/ releasedetail.cfm?ReleaseID=331827.
5. Medivation press release, Mar 3, 2010. http://investors.medivation.com/ releasedetail.cfm?ReleaseID=448818.
6. www.medivation.com.